Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana C. Chang, Ahmed Mostafa, Madhubanti Basu, Sanghita Sarkar, Simran Panjwani, Yaelyn H. Ha, Yao Ma, Chengjin Ye, Qian Wang, Todd Jason Green, James L. Kizziah, Nathaniel B. Erdmann, P. A. Goepfert, , James J. Kobie
This study develops a monoclonal antibody that broadly neutralizes multiple SARS-CoV-2 variants, including JN.1, and shows its protective efficacy in mice.
npj Viruses · Nov 14, 2024Peer-reviewedImmunology